Phase 2a randomized controlled study investigating the safety and efficacy of PDA ‐002 in diabetic peripheral neuropathy-Reference-Cited by-同舟云学术

Phase 2a randomized controlled study investigating the safety and efficacy of PDA ‐002 in diabetic peripheral neuropathy

Published:2021-06-29 Issue:3 Volume:26 Page:276-289
ISSN:1085-9489
Container-title:Journal of the Peripheral Nervous System
language:en
Short-container-title:J Peripheral Nervous Sys

Author:

Gibbons Christopher H.¹^ORCID,Zhu Junhong²,Zhang Xiaokui²,Habboubi Nassir²,Hariri Robert²,Veves Aristidis³

Affiliation:

1. Department of Neurology, Beth Israel Deaconess Medical Center Harvard Medical School Boston Massachusetts USA

2. Celularity, Inc. Warren New Jersey USA

3. Department of Surgery, The Rongxiang Xu, Center for Regenerative Therapeutics at Beth Israel Deaconess Medical Center Harvard Medical School Boston Massachusetts USA

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jns.12457

Reference40 articles.

1. Diabetic Neuropathy: A Position Statement by the American Diabetes Association

2. Diabetic neuropathy

3. Human Placenta-Derived Mesenchymal Stromal-Like Cells Enhance Angiogenesis via T Cell-Dependent Reprogramming of Macrophage Differentiation

4. Placenta-derived adherent cells attenuate hyperalgesia and neuroinflammatory response associated with perineural inflammation in rats

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A muscarinic receptor antagonist reverses multiple indices of diabetic peripheral neuropathy: preclinical and clinical studies using oxybutynin;Acta Neuropathologica;2024-03-25

2. Repeat intramuscular transplantation of human dental pulp stromal cells is more effective in sustaining Schwann cell survival and myelination for functional recovery after onset of diabetic neuropathy;Cytotherapy;2023-11

3. Transient Fever: the Sole Treatment-Related Adverse Event associated with Mesenchymal Stromal Cells and Solid Clues from the Real World;Current Stem Cell Research & Therapy;2023-10-31